The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of ...
Jun 6, 2016
0
44
Manchester scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia, according to a study published in the journal Cell Death and Disease today.
Apr 8, 2016
0
14
For decades, doctors and scientists have predicted that personalized medicine—tailoring drug doses and combinations to people's specific diseases and body chemistry—would be the future of health care.
Apr 7, 2016
0
46
One in six older adults now regularly use potentially deadly combinations of prescription and over-the-counter medications and dietary supplements—a two-fold increase over a five-year period, according to new research at ...
Mar 21, 2016
0
5
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast growing type of pediatric brain cancer. The study was ...
Mar 14, 2016
0
38
A two-drug preventive treatment greatly reduces the severity of malaria during pregnancy, according to a study funded by the National Institutes of Health. The treatment provides an alternative for many parts of Africa where ...
Mar 9, 2016
0
34
Neuroblastoma is a rare cancer that develops in very early forms of nerve cells in the embryo or fetus, and it accounts for the most pediatric deaths for any tumor outside of the brain. The most lethal form of this tumor ...
Mar 7, 2016
0
810
Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a 5-year survival rate at only 18 percent, the development of new and improved treatment ...
Feb 17, 2016
0
10
(Medical Xpress)—It's a good news/bad news scenario: Researchers have made a new discovery about HIV that will redirect curative strategies toward latent reservoirs of HIV—that's the good news. The bad news is that they ...
Patients with hepatitis C have yet another advanced treatment option, as the Food on Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck.
Jan 28, 2016
0
2
